Protara Therapeutics, Inc.TARANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank85
3Y CAGR+1.9%
5Y CAGR-0.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+1.9%/yr
vs +18.3%/yr prior
5Y CAGR
-0.4%/yr
Consistent
Acceleration
-16.5pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.92M | +25.6% |
| 2024 | $17.45M | -6.3% |
| 2023 | $18.62M | -10.2% |
| 2022 | $20.74M | -21.5% |
| 2021 | $26.40M | +18.0% |
| 2020 | $22.36M | +153.7% |
| 2019 | $8.82M | -16.6% |
| 2018 | $10.57M | +24.0% |
| 2017 | $8.53M | -12.2% |
| 2016 | $9.71M | - |